Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease.
D000978:Antiparkinson Agents / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D008775:Methylprednisolone / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D009459:Neuroleptic Malignant Syndrome / Q000453:epidemiology* / Q000209:etiology*; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D018696:Neuroprotective Agents; D008775:Methylprednisolone